Christie et al., 2023 - Google Patents
Trigger and substrate mapping and ablation for ventricular fibrillation in the structurally normal heartChristie et al., 2023
View HTML- Document ID
- 2319557827576456423
- Author
- Christie S
- Idris S
- Bennett R
- Deyell M
- Roston T
- Laksman Z
- Publication year
- Publication venue
- Journal of Cardiovascular Development and Disease
External Links
Snippet
Sudden cardiac death (SCD) represents approximately 50% of all cardiovascular mortality in the United States. The majority of SCD occurs in individuals with structural heart disease; however, around 5% of individuals have no identifiable cause on autopsy. This proportion is …
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Detecting, measuring or recording for diagnostic purposes; Identification of persons
- A61B5/04—Detecting, measuring or recording bioelectric signals of the body of parts thereof
- A61B5/0402—Electrocardiography, i.e. ECG
- A61B5/0452—Detecting specific parameters of the electrocardiograph cycle
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation, e.g. heart pace-makers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Padala et al. | Left bundle branch pacing is the best approach to physiological pacing | |
| Heckman et al. | Comparing ventricular synchrony in left bundle branch and left ventricular septal pacing in pacemaker patients | |
| Stevenson et al. | Catheter ablation for ventricular tachycardia | |
| Ivanovski et al. | Biventricular versus conduction system pacing after atrioventricular node ablation in heart failure patients with atrial fibrillation | |
| Anderson et al. | Focal ventricular tachycardias in structural heart disease: prevalence, characteristics, and clinical outcomes after catheter ablation | |
| Chakrabarti et al. | Arrhythmic mitral valve prolapse and mitral annular disjunction: clinical features, pathophysiology, risk stratification, and management | |
| Kuniewicz et al. | Left ventricular summit—concept, anatomical structure and clinical significance | |
| Demșa et al. | Persistent left superior vena cava with absent right superior vena cava and discrete subaortic stenosis diagnosed in a patient with sick sinus syndrome: a case report and brief review of the literature | |
| Gardas et al. | The effects of his bundle pacing compared to classic resynchronization therapy in patients with pacing-induced cardiomyopathy | |
| Unland et al. | Find me if you can: first clinical experience using the novel CARTOFINDER algorithm in a routine workflow for atrial fibrillation ablation | |
| Chen et al. | Extracardiac vagal stimulation-assisted cardioneuroablation: Dynamically evaluating the impact of sequential ganglionated plexus ablation on vagal control of SAN and AVN in patients with sinoatrial node dysfunction | |
| Stec et al. | Shared decision making and cardioneuroablation allow discontinuation of permanent pacing in patients with vagally mediated bradycardia | |
| Christie et al. | Trigger and substrate mapping and ablation for ventricular fibrillation in the structurally normal heart | |
| Qiu et al. | Potential application of pulsed field ablation in ventricular arrhythmias | |
| Kataoka et al. | Catheter ablation for tachyarrhythmias in left ventricular assist device recipients: clinical significance and technical tips | |
| Ntiloudi et al. | Arrhythmias in patients with congenital heart disease: an ongoing morbidity | |
| Masuda et al. | Conversion to Purkinje-related monomorphic ventricular tachycardia after ablation of ventricular fibrillation in ischemic heart disease | |
| Ward et al. | Idiopathic ventricular tachycardia | |
| Vázquez-Calvo et al. | Ventricular tachycardia ablation guided by functional substrate mapping: practices and outcomes | |
| Sciacca et al. | Combination of high-density and Coherent mapping for ablation of ventricular arrhythmia in patients with structural heart disease | |
| Repp et al. | Opportunities and challenges in catheter-based irreversible electroporation for ventricular tachycardia | |
| Agnino et al. | Robotic-Assisted Epicardial Hybrid Ablation and Left Appendage Closure in Persistent Atrial Fibrillation: First European Experience | |
| Stanciulescu et al. | Ventricular Tachycardia Catheter Ablation: Retrospective Analysis and Prospective Outlooks—A Comprehensive Review | |
| Nguyên et al. | Ultra-High-Frequency ECG in Cardiac Pacing and Cardiac Resynchronization Therapy: From Technical Concept to Clinical Application | |
| Okólska et al. | Prevalence of arrhythmia in adults after fontan operation |